IBDEI0OJ ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11699,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11699,1,2,0)
 ;;=2^V40.39
 ;;^UTILITY(U,$J,358.3,11699,1,5,0)
 ;;=5^Behavioral Problem NEC
 ;;^UTILITY(U,$J,358.3,11699,2)
 ;;=^340622
 ;;^UTILITY(U,$J,358.3,11700,0)
 ;;=V65.19^^53^669^45
 ;;^UTILITY(U,$J,358.3,11700,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11700,1,2,0)
 ;;=2^V65.19
 ;;^UTILITY(U,$J,358.3,11700,1,5,0)
 ;;=5^Person Consulting on Behalf of Pt
 ;;^UTILITY(U,$J,358.3,11700,2)
 ;;=^329985
 ;;^UTILITY(U,$J,358.3,11701,0)
 ;;=V66.7^^53^669^8
 ;;^UTILITY(U,$J,358.3,11701,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11701,1,2,0)
 ;;=2^V66.7
 ;;^UTILITY(U,$J,358.3,11701,1,5,0)
 ;;=5^Encounter for Palliative Care
 ;;^UTILITY(U,$J,358.3,11701,2)
 ;;=^89209
 ;;^UTILITY(U,$J,358.3,11702,0)
 ;;=V11.4^^53^669^20
 ;;^UTILITY(U,$J,358.3,11702,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11702,1,2,0)
 ;;=2^V11.4
 ;;^UTILITY(U,$J,358.3,11702,1,5,0)
 ;;=5^Hx Combat/Operational Stress
 ;;^UTILITY(U,$J,358.3,11702,2)
 ;;=^339674
 ;;^UTILITY(U,$J,358.3,11703,0)
 ;;=V60.1^^53^669^22
 ;;^UTILITY(U,$J,358.3,11703,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11703,1,2,0)
 ;;=2^V60.1
 ;;^UTILITY(U,$J,358.3,11703,1,5,0)
 ;;=5^Inadequate Housing
 ;;^UTILITY(U,$J,358.3,11703,2)
 ;;=^295540
 ;;^UTILITY(U,$J,358.3,11704,0)
 ;;=V62.84^^53^669^49
 ;;^UTILITY(U,$J,358.3,11704,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11704,1,2,0)
 ;;=2^V62.84
 ;;^UTILITY(U,$J,358.3,11704,1,5,0)
 ;;=5^Suicidal Ideation
 ;;^UTILITY(U,$J,358.3,11704,2)
 ;;=^332876
 ;;^UTILITY(U,$J,358.3,11705,0)
 ;;=V62.85^^53^669^18
 ;;^UTILITY(U,$J,358.3,11705,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11705,1,2,0)
 ;;=2^V62.85
 ;;^UTILITY(U,$J,358.3,11705,1,5,0)
 ;;=5^Homicidal Ideation
 ;;^UTILITY(U,$J,358.3,11705,2)
 ;;=^339690
 ;;^UTILITY(U,$J,358.3,11706,0)
 ;;=V58.61^^53^669^25
 ;;^UTILITY(U,$J,358.3,11706,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11706,1,2,0)
 ;;=2^V58.61
 ;;^UTILITY(U,$J,358.3,11706,1,5,0)
 ;;=5^L/T (Current) Anticoagulant Use
 ;;^UTILITY(U,$J,358.3,11706,2)
 ;;=^303459
 ;;^UTILITY(U,$J,358.3,11707,0)
 ;;=V58.62^^53^669^24
 ;;^UTILITY(U,$J,358.3,11707,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11707,1,2,0)
 ;;=2^V58.62
 ;;^UTILITY(U,$J,358.3,11707,1,5,0)
 ;;=5^L/T (Current) Antibiotics Use
 ;;^UTILITY(U,$J,358.3,11707,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,11708,0)
 ;;=V58.63^^53^669^26
 ;;^UTILITY(U,$J,358.3,11708,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11708,1,2,0)
 ;;=2^V58.63
 ;;^UTILITY(U,$J,358.3,11708,1,5,0)
 ;;=5^L/T (Current) Antiplts/Antithrmbtcs
 ;;^UTILITY(U,$J,358.3,11708,2)
 ;;=^329978
 ;;^UTILITY(U,$J,358.3,11709,0)
 ;;=V58.64^^53^669^30
 ;;^UTILITY(U,$J,358.3,11709,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11709,1,2,0)
 ;;=2^V58.64
 ;;^UTILITY(U,$J,358.3,11709,1,5,0)
 ;;=5^L/T (Current) NSAIDS Use
 ;;^UTILITY(U,$J,358.3,11709,2)
 ;;=^329979
 ;;^UTILITY(U,$J,358.3,11710,0)
 ;;=V58.65^^53^669^32
 ;;^UTILITY(U,$J,358.3,11710,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11710,1,2,0)
 ;;=2^V58.65
 ;;^UTILITY(U,$J,358.3,11710,1,5,0)
 ;;=5^L/T (Current) Steroids Use
 ;;^UTILITY(U,$J,358.3,11710,2)
 ;;=^329980
 ;;^UTILITY(U,$J,358.3,11711,0)
 ;;=V58.66^^53^669^27
 ;;^UTILITY(U,$J,358.3,11711,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11711,1,2,0)
 ;;=2^V58.66
 ;;^UTILITY(U,$J,358.3,11711,1,5,0)
 ;;=5^L/T (Current) Aspirin Use
 ;;^UTILITY(U,$J,358.3,11711,2)
 ;;=^331584
 ;;^UTILITY(U,$J,358.3,11712,0)
 ;;=V58.67^^53^669^29
 ;;^UTILITY(U,$J,358.3,11712,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11712,1,2,0)
 ;;=2^V58.67
 ;;
 ;;$END ROU IBDEI0OJ
